Methamphetamine Addiction
Conditions
Keywords
Methamphetamine, Drug Abuse, Drug Treatment, Addiction, Meth, Treatment for Methamphetamine Dependence
Brief summary
The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants will attend research visits twice per week, and will receive individual counseling sessions once per week for all 9 weeks. 50% of the participants will receive the active medication while the other 50% will receive the placebo (sugar pill). Neither the participant or the study team will know if the participant is receiving the placebo or active drug.
Interventions
1 week placebo and 8 weeks 60mg d-AMP QD.
DRUGPlacebo
9 weeks of placebo 60mg capsules QD.
Sponsors
California Pacific Medical Center Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* 18-50 yrs. old
Exclusion criteria
* pregnant or lactating females * Contact site for additional information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjects treated with dextroamphetamine will have better outcomes than subjects treated with placebo, as indicated by the number of urine samples that do not indicate new use of MA (the primary outcome measure) | Twice per week for 8 weeks |
Countries
United States
Outcome results
None listed